Delivery Order SPE2DB24D2101-SPE2DB24FKFUF
Award Date
8/8/24
Potential Completion Date
8/9/24
Potential Value
$64K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $35,268.40 delivery order contract is for the supply of Rebif 44 mcg/0.5 mL syringes, a multiple sclerosis medication. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML medical supplies. The contract, valued at $49,348.26, is a delivery order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. This contract is not designated with a set-aside requirement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $64,142.21, is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of June 26, 2024 and is a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This federal contract award, valued at $4,101.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC), covers the provision of REBIF SYR 0.5ML 12S, a pharmaceutical product. The contract has a firm fixed price and is set to run until November 13, 2024. While the original solicitation is not provided, the contract appears to be part of a...
This federal contract award, valued at $21,075.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. As a general...
This federal contract award, valued at $4,664.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for...
This is a $8,202.62 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a medication used in the treatment of multiple sclerosis. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,422.66, is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML medical products. The contract is a firm fixed-price delivery order with an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides pharmaceutical and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $18,374.02 firm-fixed-price delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, with a completion date of August 7, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,938.51 firm fixed price delivery order is for the supply of the specialty medication Rebif 44 mcg/0.5 ml syringe, with a completion date of December 27, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...